Filament Health Corp (NEO:FH) — Market Cap & Net Worth
Market Cap & Net Worth: Filament Health Corp (FH)
Filament Health Corp (NEO:FH) has a market capitalization of $1.89 Million (CA$2.62 Million) as of May 2, 2026. Listed on the NEO stock exchange, this Canada-based company holds position #29743 globally and #1508 in its home market, demonstrating a -60.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Filament Health Corp's stock price CA$0.01 by its total outstanding shares 261794000 (261.79 Million). Analyse FH cash generation efficiency to see how efficiently the company converts income to cash.
Filament Health Corp Market Cap History: 2021 to 2025
Filament Health Corp's market capitalization history from 2021 to 2025. Data shows change from $53.03 Million to $1.89 Million (-61.08% CAGR).
Filament Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Filament Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.21x
Filament Health Corp's market cap is 9.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $53.03 Million | $162.50K | -$9.25 Million | 326.31x | N/A |
| 2022 | $10.42 Million | $364.50K | -$16.47 Million | 28.58x | N/A |
| 2023 | $17.04 Million | $2.13 Million | -$5.32 Million | 8.00x | N/A |
| 2024 | $5.68 Million | $616.68K | -$4.97 Million | 9.21x | N/A |
Competitor Companies of FH by Market Capitalization
Companies near Filament Health Corp in the global market cap rankings as of May 2, 2026.
Key companies related to Filament Health Corp by market ranking:
- Scancell Hldgs Plc (LSE:SCLP): Ranked #29734 globally with a market cap of $1.91 Million USD ( GBX15.67 Billion GBX).
- Bastion Minerals Ltd (AU:BMO): Ranked #29735 globally with a market cap of $1.91 Million USD ( AU$2.69 Million AUD).
- KINGS ENTERTAINMENT GROUP (F:L12): Ranked #29744 globally with a market cap of $1.89 Million USD ( €1.62 Million EUR).
- Young & Co.'s Brewery P.L.C (LSE:YNGN): Ranked #29745 globally with a market cap of $1.89 Million USD ( GBX15.51 Billion GBX).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #29734 | Scancell Hldgs Plc | LSE:SCLP | $1.91 Million | GBX15.10 |
| #29735 | Bastion Minerals Ltd | AU:BMO | $1.91 Million | AU$0.04 |
| #29744 | KINGS ENTERTAINMENT GROUP | F:L12 | $1.89 Million | €0.01 |
| #29745 | Young & Co.'s Brewery P.L.C | LSE:YNGN | $1.89 Million | GBX662.00 |
Filament Health Corp Historical Marketcap From 2021 to 2025
Between 2021 and today, Filament Health Corp's market cap moved from $53.03 Million to $ 1.89 Million, with a yearly change of -61.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | CA$1.89 Million | -66.67% |
| 2024 | CA$5.68 Million | -66.67% |
| 2023 | CA$17.04 Million | +63.64% |
| 2022 | CA$10.42 Million | -80.36% |
| 2021 | CA$53.03 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Filament Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.89 Million USD |
| MoneyControl | $1.89 Million USD |
| MarketWatch | $1.89 Million USD |
| marketcap.company | $1.89 Million USD |
| Reuters | $1.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Filament Health Corp
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more